👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr David Thomson
Oncology
English
8,525+
Patients seen
2
Years in practice
12
Publications
1
Languages spoken
About
• Head and neck cancer oncologist, treating patients with high precision radiotherapy, proton beam therapy and drug therapies
• MAHSC honorary Professor at the University of Manchester
• Honorary Clinical Professor of Oncology at the University of Liverpool
• Clinical Lead for Head at Neck Cancer at the NHS Greater Manchester Cancer Alliance
• Clinical Lead for Research at the NHS Greater Manchester Cancer Alliance
Professor Thomson has a substantial national and international reputation in his field of head and neck oncology. He qualified form Oxford University Medical School in 2004, with a First class honours degree. He also has a Doctorate of Medicine research degree from the University of Manchester.
He is an honorary MAHSC Chair and Professor of Clinical Oncology at the University of Manchester and Honorary Clinical Professor of Oncology at the University of Liverpool. He is the clinical lead for head and neck cancer in Greater Manchester (2018-), and for the head and neck team at The Christie.
Professor Thomson has co-authored national and international guidelines for the treatment of head and neck cancer. He was an invited expert reviewer for the American and European Radiation Societies (ASTRO and ESTRO) guidelines for the treatment of head and neck cancers. He led for ESTRO on the expert international consensus guidance for the management of head and neck cancer during the COVID-19 pandemic. He is a member of the NHS England national proton commissioning panels for head and neck cancer and exceptional indications (2019-).
He is also the NHS Greater Manchester Cancer Clinical Lead for Research (2022-), and is Chief Investigator for major late phase multi-centre head and neck cancer clinical trials. He has given numerous invited talks on the treatment of head and neck cancer, has published work in high impact journals including Lancet Oncology and Journal of Clinical Oncology, and served as associate editor for the International Journal of Radiation Oncology Biology Physics (2020-2024).
• MAHSC honorary Professor at the University of Manchester
• Honorary Clinical Professor of Oncology at the University of Liverpool
• Clinical Lead for Head at Neck Cancer at the NHS Greater Manchester Cancer Alliance
• Clinical Lead for Research at the NHS Greater Manchester Cancer Alliance
Professor Thomson has a substantial national and international reputation in his field of head and neck oncology. He qualified form Oxford University Medical School in 2004, with a First class honours degree. He also has a Doctorate of Medicine research degree from the University of Manchester.
He is an honorary MAHSC Chair and Professor of Clinical Oncology at the University of Manchester and Honorary Clinical Professor of Oncology at the University of Liverpool. He is the clinical lead for head and neck cancer in Greater Manchester (2018-), and for the head and neck team at The Christie.
Professor Thomson has co-authored national and international guidelines for the treatment of head and neck cancer. He was an invited expert reviewer for the American and European Radiation Societies (ASTRO and ESTRO) guidelines for the treatment of head and neck cancers. He led for ESTRO on the expert international consensus guidance for the management of head and neck cancer during the COVID-19 pandemic. He is a member of the NHS England national proton commissioning panels for head and neck cancer and exceptional indications (2019-).
He is also the NHS Greater Manchester Cancer Clinical Lead for Research (2022-), and is Chief Investigator for major late phase multi-centre head and neck cancer clinical trials. He has given numerous invited talks on the treatment of head and neck cancer, has published work in high impact journals including Lancet Oncology and Journal of Clinical Oncology, and served as associate editor for the International Journal of Radiation Oncology Biology Physics (2020-2024).
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr David Thomson
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncology
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 3,025 |
| Annual physical exam | 99395 | 2,271 |
| Vaccination administration | 90471 | 1,407 |
| Minor procedure (skin) | 17110 | 1,856 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 720.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 630.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 7 · i10: 14
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.9972/euroclin.2025.0 · PMID: 37013201 · cited by 81
-
European registry analysis of Oncology outcomes
DOI: 10.2974/euroclin.2024.1 · PMID: 32891941 · cited by 3
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.6491/euroclin.2023.2 · PMID: 39061357 · cited by 197
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.david.thomson.2@euroclinics.example
